Health-Related Quality of Life Improvements in Moderate to Very Severe Chronic Obstructive Pulmonary Disease Patients on Nebulized Glycopyrrolate: Evidence from the GOLDEN Studies

Những quyển sách tương tự

• Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk Factors
  Bằng: Ferguson, Gary T., et al.
  Được phát hành: (2018)
• Effect of background long-acting beta(2)-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
  Bằng: Kerwin, Edward M, et al.
  Được phát hành: (2018)
• Dose selection for glycopyrrolate/eFlow(®) phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies
  Bằng: Donohue, James F., et al.
  Được phát hành: (2017)
• In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution
  Bằng: Pham, Stephen, et al.
  Được phát hành: (2018)
• Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4
  Bằng: Ohar, Jill, et al.
  Được phát hành: (2018)